Elite Pharmaceuticals Inc (ELTP)
0.6168
0.00 (0.00%)
USD |
OTCM |
Nov 22, 15:59
Elite Pharmaceuticals Total Liabilities (Quarterly): 40.93M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 40.93M |
| June 30, 2024 | 29.60M |
| March 31, 2024 | 26.07M |
| December 31, 2023 | 28.28M |
| September 30, 2023 | 25.62M |
| June 30, 2023 | 16.38M |
| March 31, 2023 | 11.94M |
| December 31, 2022 | 22.54M |
| September 30, 2022 | 23.15M |
| June 30, 2022 | 22.58M |
| March 31, 2022 | 9.927M |
| December 31, 2021 | 9.157M |
| September 30, 2021 | 10.12M |
| June 30, 2021 | 11.29M |
| March 31, 2021 | 10.04M |
| December 31, 2020 | 12.03M |
| September 30, 2020 | 12.99M |
| June 30, 2020 | 16.03M |
| March 31, 2020 | 14.30M |
| December 31, 2019 | 15.01M |
| September 30, 2019 | 12.69M |
| June 30, 2019 | 12.24M |
| March 31, 2019 | 26.91M |
| December 31, 2018 | 12.74M |
| September 30, 2018 | 11.65M |
| Date | Value |
|---|---|
| June 30, 2018 | 11.50M |
| March 31, 2018 | 12.41M |
| December 31, 2017 | 12.18M |
| September 30, 2017 | 11.92M |
| June 30, 2017 | 16.20M |
| March 31, 2017 | 8.647M |
| December 31, 2016 | 10.15M |
| September 30, 2016 | 12.39M |
| June 30, 2016 | 17.52M |
| March 31, 2016 | 20.51M |
| December 31, 2015 | 29.20M |
| September 30, 2015 | 16.21M |
| June 30, 2015 | 45.23M |
| March 31, 2015 | 25.65M |
| December 31, 2014 | 56.24M |
| September 30, 2014 | 79.25M |
| June 30, 2014 | 108.42M |
| March 31, 2014 | 105.52M |
| December 31, 2013 | 23.20M |
| September 30, 2013 | 23.26M |
| June 30, 2013 | 16.79M |
| March 31, 2013 | 19.80M |
| December 31, 2012 | 22.73M |
| September 30, 2012 | 31.88M |
| June 30, 2012 | 33.54M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.157M
Minimum
Dec 2021
40.93M
Maximum
Sep 2024
18.40M
Average
15.52M
Median
Total Liabilities (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 1.438B |
| BioCardia Inc | 3.514M |
| Zevra Therapeutics Inc | 121.78M |
| Verrica Pharmaceuticals Inc | 66.98M |
| Terns Pharmaceuticals Inc | 13.76M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 88.20M |
| Shareholders Equity (Quarterly) | 47.27M |
| Debt to Equity Ratio | 0.1575 |
| Current Ratio | 3.524 |
| Net Debt Paydown Yield | 0.02% |